Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: A randomised, double-blind, controlled clinical trial

Lancet

Volumn 366, Issue 9484, 2005, Pages 463-471

  Aaron, Shawn D ^a,o   Vandemheen, Katherine L ^a   Ferris, Wendy ^b   Fergusson, Dean ^a   Tullis, Elizabeth ^c   Haase, David ^d   Berthiaume, Yves ^e   Brown, Neil ^f   Wilcox, Pearce ^g   Yozghatlian, Veronica ^h   Bye, Peter ^h   Bell, Scott ⁱ   Chan, Francis ^b   Rose, Barbara ^j   Jeanneret, Alphonse ^e   Stephenson, Anne ^c   Noseworthy, Mary ^l   Freitag, Andreas ^k   Paterson, Nigel ^m   Doucette, Steve ^a   Harbour, Colin ^j   Ruel, Michel ⁿ   MacDonald, Noni ^d   more..

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ THE PRINCE CHARLES HOSPITAL   (Australia)

^j UNIVERSITY OF SYDNEY   (Australia)

^k MCMASTER UNIVERSITY   (Canada)

^l MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^m UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁿ UNIVERSITÉ LAVAL   (Canada)

^o UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DEOXYRIBONUCLEASE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CELL DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DYSPNEA; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 23444457294     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67060-2     Document Type: Article

References (29)

1. R Wenzel, M Edmond Managing antibiotic resistance NEJM 343 2000 1961 1963
2. H Goossens, M Ferech, R Vander Stichele, M Elseviers Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 587
3. Lechtzin N, John M, Irizarry R, Merlo C, Diette G, Boyle M. Outcomes of adults with cystic. brosis infected with antibiotic resistant Pseudomonas aeruginosa. Respiration (in press)'.
4. M Rosenfeld, J Emerson, J Williams-Warren Defining a pulmonary exacerbation in cystic fibrosis J Pediatr 139 2001 359 365
5. Cystic Fibrosis Foundation Microbiology and infectious disease in cystic fibrosis. V (Section 1) 1994 Cystic Fibrosis Foundation Bethesda 1 26
6. A Smith, C Doershuk, D Goldmann Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis J Pediatr 134 1999 413 421
7. WE Regelmann, GR Elliott, WJ Warwick, CC Clawson Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone Am Rev Respir Dis 141 1990 914 921
8. HE Elphick, A Tan Single versus combination intravenous antibiotic therapy for people with cystic fibrosis Cochrane Database Syst Rev 1 2001 CD002007.pub2
9. SD Aaron, W Ferris, DA Henry, DP Speert, NE MacDonald Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia Am J Respir Crit Care Med 161 2000 1206 1212
10. BJ Lang, SD Aaron, W Ferris, PC Hebert, NE MacDonald Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa Am J Respir Crit Care Med 162 2000 2241 2245
11. W Ferris, N Macdonald, A MacKenzie Multiple combination antibiotic testing for antibiotic synergy in multiresistant Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis ICAAC Proc 1 1997 E147
12. L Saiman, F Mehar, WW Niu, HC Neu, KJ Shaw, G Miller, A Prince Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation Clin Infect Dis 23 1996 532 537
13. RN Chernish, SD Aaron Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis Curr Opin Pulm Med 9 2003 509 515
14. DA Mahler, DH Weinberg, CK Wells, AR Feinstein The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 1984 751 758
15. JG Lijmer, BW Mol, S Heisterkamp, GJ Bonsel, MH Prins, JH van der Meulen, PM Bossuyt Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282 1999 1061 1066
16. R Jaeschke, GH Guyatt, DL Sackett Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 271 1994 703 777
17. JJ Deeks Using evaluations of diagnostic tests: understanding their limitations and making the most of available evidence Ann Oncol 10 1999 761 768
18. A Perrier, PM Roy, O Sanchez Multidetector-row computed tomography in suspected pulmonary embolism N Engl J Med 352 2005 1760 1768
19. L Saiman, Y Chen, PS Gabriel, C Knirsch Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis Antimicrob Agents Chemother 46 2002 1105 1107
20. P San Gabriel, J Zhou, S Tabibi, Y Chen, M Trauzzi, L Saiman Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis Antimicrob Agents Chemother 48 2004 168 171
21. L Saiman, BC Marshall, N Mayer-Hamblett Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial JAMA 290 2003 1749 1756
22. A Equi, IM Balfour-Lynn, A Bush, M Rosenthal Long-term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial Lancet 360 2002 978 984
23. A Smith, SB Fiel, N Mayer-Hamblett, B Ramsey, JL Burns Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration. Lack of association in cystic fibrosis Chest 123 2003 1495 1502
24. SD Aaron, K Ramotar, W Ferris Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med 169 2004 781 782
25. PK Singh, AL Schaefer, MR Parsek, TO Moninger, MJ Welsh, EP Greenberg Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms Nature 407 2000 762 764
26. E Drenkard, FM Ausubel Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation Nature 416 2002 740 743
27. W Costerton, R Veeh, M Shirtliff, M Pasmore, C Post The application of biofilm science to the study and control of chronic bacterial infections J Clin Invest 112 2003 1466 1477
28. SD Aaron, W Ferris, K Ramotar, K Vandemheen, F Chan, R Saginur Single and combination antibiotic susceptibilities of planktonic, adherent and biofilm-grown Pseudomonas aeruginosa cultured from CF sputum J Clin Microbiol 40 2002 4172 4179
29. S Moskowitz, J Foster, J Emerson, J Burns Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis J Clin Microbiol 42 2004 1915 1922